Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan

BACKGROUND: Interstitial lung disease/pneumonitis (ILD/pneumonitis) has been identified as a drug-related adverse event of special interest of trastuzumab deruxtecan (T-DXd), but there were a few reports of T-DXd-related ILD/pneumonitis in clinical practice. METHODS: Between May 25, 2020 (the launch...

Descripción completa

Detalles Bibliográficos
Autores principales: Baba, Tomohisa, Kusumoto, Masahiko, Kato, Terufumi, Kurihara, Yasuyuki, Sasaki, Shinichi, Oikado, Katsunori, Saito, Yoshinobu, Endo, Masahiro, Fujiwara, Yutaka, Kenmotsu, Hirotsugu, Sata, Masafumi, Takano, Toshimi, Kato, Ken, Hirata, Koji, Katagiri, Tomomi, Saito, Hanako, Kuwano, Kazuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687185/
https://www.ncbi.nlm.nih.gov/pubmed/37787866
http://dx.doi.org/10.1007/s10147-023-02414-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687185/
https://www.ncbi.nlm.nih.gov/pubmed/37787866
http://dx.doi.org/10.1007/s10147-023-02414-x

Ejemplares similares